{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:00:41Z","timestamp":1791486041537,"version":"4.3.4"},"reference-count":170,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Background: Cardiomyopathies are a heterogeneous group of pathologies characterized by structural and functional alterations of the heart. Aims: The purpose of this narrative review is to focus on the most important cardiomyopathies and their epidemiology, diagnosis, and management. Methods: Clinical trials were identified by Pubmed until 30 March 2021. The search keywords were \u201ccardiomyopathies, sudden cardiac arrest, dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy, arrhythmogenic cardiomyopathy (ARCV), takotsubo syndrome\u201d. Results: Hypertrophic cardiomyopathy (HCM) is the most common primary cardiomyopathy, with a prevalence of 1:500 persons. Dilated cardiomyopathy (DCM) has a prevalence of 1:2500 and is the leading indication for heart transplantation. Restrictive cardiomyopathy (RCM) is the least common of the major cardiomyopathies, representing 2% to 5% of cases. Arrhythmogenic cardiomyopathy (ARCV) is a pathology characterized by the substitution of the myocardium by fibrofatty tissue. Takotsubo cardiomyopathy is defined as an abrupt onset of left ventricular dysfunction in response to severe emotional or physiologic stress. Conclusion: In particular, it has been reported that HCM is the most important cause of sudden death on the athletic field in the United States. It is needless to say how important it is to know which changes in the heart due to physical activity are normal, and when they are pathological.<\/jats:p>","DOI":"10.3390\/ijms22147722","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T21:39:15Z","timestamp":1626730755000},"page":"7722","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":202,"title":["Cardiomyopathies: An Overview"],"prefix":"10.3390","volume":"22","author":[{"given":"Tiziana","family":"Ciarambino","sequence":"first","affiliation":[{"name":"Internal Emergency Department, Hospital of Marcianise, 81037 ASL Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Menna","sequence":"additional","affiliation":[{"name":"Department of Medical Science, University of Campania, L. Vanvitelli, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Sansone","sequence":"additional","affiliation":[{"name":"Department of Medical Science, University of Campania, L. Vanvitelli, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Giordano","sequence":"additional","affiliation":[{"name":"Department of Medical Science, University of Campania, L. Vanvitelli, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","article-title":"The MOGE(S) classification of cardiomyopathy for clinicians","volume":"64","author":"Arbustini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"(1980). Report of the WHO\/ISFC task force on the definition and classification of cardiomyopathies. Br. Heart J., 44, 672.","DOI":"10.1136\/hrt.44.6.672"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"ref_5","unstructured":"Mahmaljy, H., Yelamanchili, V.S., and Singhal, M. (2021). Dilated Cardiomyopathy, StatPearls Publishing."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/joim.12944","article-title":"Dilated cardiomyopathy: From epidemiologic to genetic phenotypes: A translational review of current literature","volume":"286","author":"Reichart","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/0002-9149(92)90901-A","article-title":"Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop)","volume":"69","author":"Manolio","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The Diagnosis and Evaluation of Dilated Cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurjhf\/hfp037","article-title":"Alcohol abuse and heart failure","volume":"11","author":"Laonigro","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: Pathophysiology, course, monitoring, management, prevention, and research directions","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.122249299","article-title":"Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy","volume":"99","author":"Ozcelik","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","article-title":"Genetic mutations and mechanisms in dilated cardiomyopathy","volume":"123","author":"McNally","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/FJC.0000000000000007","article-title":"Cardiac titin and heart disease","volume":"63","author":"LeWinter","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population","volume":"49","author":"Adami","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/302869","article-title":"Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy","volume":"66","author":"Ricci","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Truszkowska, G.T., Bilinska, Z.T., Kosi\u0144ska, J., \u015aleszycka, J., Rydzanicz, M., Sobieszcza\u0144ska-Ma\u0142ek, M., Franaszczyk, M., Bili\u0144ska, M., Stawi\u0144ski, P., and Michalak, E. (2015). A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations. BMC Med. Genet., 16.","DOI":"10.1186\/s12881-015-0167-0"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCEP.111.962050","article-title":"Dilated cardiomyopathy","volume":"6","author":"Lakdawala","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: AJACC white paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCIMAGING.113.000416","article-title":"Cardiac magnetic resonance assessment of myocarditis","volume":"6","author":"Friedrich","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11886-013-0375-1","article-title":"Genetic evaluation of dilated cardiomyopathy","volume":"15","author":"Morales","year":"2013","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.hrthm.2014.04.042","article-title":"Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy","volume":"11","author":"Beckermann","year":"2014","journal-title":"Heart Rhythm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defi brillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Thune","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","article-title":"Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial","volume":"288","author":"Wilkoff","year":"2002","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.hlc.2011.06.004","article-title":"A randomised, placebo-controlled trial of carvedilol in early familial dilated cardiomyopathy","volume":"20","author":"Yeoh","year":"2011","journal-title":"Heart Lung Circ."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","article-title":"Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study)","volume":"36","author":"Martino","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_39","first-page":"e783","article-title":"ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"ref_40","first-page":"456","article-title":"Contribution \u00e0 l\u2019\u00e9tude des r\u00e9tr\u00e9cissements de l\u2019orifi ce ventriculo-aortique","volume":"3","author":"Vulpian","year":"1868","journal-title":"Arch. Physiol."},{"key":"ref_41","first-page":"221","article-title":"Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis","volume":"106","author":"Brock","year":"1957","journal-title":"Guys Hosp. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults","volume":"20","author":"Teare","year":"1958","journal-title":"Br. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical Course and Management of Hypertrophic Cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2004.03.007","article-title":"Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study)","volume":"93","author":"Maron","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: A population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/eurheartj\/ehx527","article-title":"Women with hypertrophic cardiomyopathy have worse survival","volume":"38","author":"Geske","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4065\/80.4.463","article-title":"Sarcomeric genotyping in hypertrophic cardiomyopathy","volume":"80","author":"Ommen","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2004.04.039","article-title":"Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy","volume":"44","author":"Jaeger","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"389","author":"Veselka","year":"2017","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ng0596-63","article-title":"Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle","volume":"13","author":"Poetter","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0735-1097(96)00538-4","article-title":"Clinical features of hypertrophic cardiomyopathy caused by mutation of a \u201chot spot\u201d in the alpha-tropomyosin gene","volume":"29","author":"Coviello","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/eurheartj\/ehm239","article-title":"Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects","volume":"28","author":"Monserrat","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy. Clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.eurheartj.a015002","article-title":"Chest pain during daily life in patients with hypertrophic cardiomyopathy: An ambulatory electrocardiographic study","volume":"17","author":"Elliott","year":"1996","journal-title":"Eur. Heart J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/0735-1097(90)90222-B","article-title":"Syncope in hypertrophic cardiomyopathy: Multivariate analysis of prognostic determinants","volume":"15","author":"Nienaber","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"189-","DOI":"10.1007\/s10741-018-9752-6","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: Prevalence, clinical impact, and management","volume":"24","author":"Garg","year":"2019","journal-title":"Heart Fail. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.amjcard.2016.07.043","article-title":"Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients with Hypertrophic Cardiomyopathy","volume":"118","author":"Chan","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Insights from the SHaRe Registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jacc.2009.02.071","article-title":"Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram","volume":"54","author":"McLeod","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.amjcard.2018.04.038","article-title":"Development of and Progression of Overt Heart Failure in Nonobstructive Hypertrophic Cardiomyopathy","volume":"122","author":"Hiemstra","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.109.914762","article-title":"Exercise Testing in Nonatherosclerotic Heart Disease: Hypertrophic Cardiomyopathy, Valvular Heart Disease, and Arrhythmias","volume":"123","author":"Morise","year":"2011","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","article-title":"Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Gimeno","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiol.14131626","article-title":"MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside","volume":"273","author":"Bogaert","year":"2014","journal-title":"Radiology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/CIRCULATIONAHA.114.014283","article-title":"Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy","volume":"132","author":"Maron","year":"2015","journal-title":"Circulation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.amjcard.2019.01.041","article-title":"Role of Preoperative Cardiovascular Magnetic Resonance in Planning Ventricular Septal Myectomy in Patients with Obstructive Hypertrophic Cardiomyopathy","volume":"123","author":"Spirito","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.52.1.88","article-title":"Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of preand postoperative assessments in 83 patients","volume":"52","author":"Morrow","year":"1975","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reductionfor hypertrophic obstructivecardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.107.698985","article-title":"Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: Correlation with direct left atrial pressure measurement at cardiac catheterization","volume":"116","author":"Geske","year":"2007","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/CIRCULATIONAHA.115.015085","article-title":"Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy","volume":"133","author":"MacIntyre","year":"2016","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): A randomised, double-blind, placebo-controlled, phase 3 trial.; EXPLORER-HCM study investigators","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehz145","article-title":"History of the discovery of Arrhythmogenic Cardiomyopathy","volume":"40","author":"Marrone","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ejhf.1534","article-title":"Definition and treatment of arrhythmogenic cardiomyopathy: An updated expert panel report","volume":"21","author":"Perry","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","article-title":"Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?","volume":"94","author":"Basso","year":"1996","journal-title":"Circulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: Proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.104.532234","article-title":"Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy","volume":"112","author":"Norman","year":"2005","journal-title":"Circulation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijcard.2003.10.037","article-title":"Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital","volume":"97","author":"Peters","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, longterm follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic Cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","article-title":"Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: A multicenter study","volume":"30","author":"Corrado","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.carpath.2005.10.004","article-title":"Arrhythmogenic right ventricular cardiomyopathy\/dysplasia: Is there a role for viruses?","volume":"15","author":"Calabrese","year":"2006","journal-title":"Cardiovasc. Pathol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/europace\/euv205","article-title":"Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy","volume":"18","author":"Zorzi","year":"2016","journal-title":"Europace"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/12.suppl_D.22","article-title":"Right ventricular cardiomyopathy: Is there evidence of an inflammatory aetiology?","volume":"12","author":"Thiene","year":"1991","journal-title":"Eur Heart J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e003631","DOI":"10.1161\/CIRCEP.115.003631","article-title":"Relationship between arrhythmogenic right ventricular cardiomyopathy and brugada syndrome: New insights from molecular biology and clinical implications","volume":"9","author":"Corrado","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cvr\/cvs218","article-title":"Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency","volume":"95","author":"Cerrone","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(09)60256-7","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"373","author":"Basso","year":"2009","journal-title":"Lancet"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2015.01.045","article-title":"Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2","volume":"65","author":"Cruz","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: An International Task Force Consensus Statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: A report from the North American ARVC Registry","volume":"54","author":"Marcus","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","article-title":"Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Dalal","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"240ra74","DOI":"10.1126\/scitranslmed.3008008","article-title":"Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy","volume":"6","author":"Asimaki","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_106","first-page":"1","article-title":"Central role for GSK3\u03b2 in the pathogenesis of arrhythmogenic cardiomyopathy","volume":"21","author":"Chelko","year":"2016","journal-title":"JCI Insight"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amjmed.2011.08.025","article-title":"The cardiovascular effects of peroxisome proliferator-activated receptor agonists","volume":"125","author":"Friedland","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.115.305227","article-title":"Empowering adult stem cells for myocardial regeneration v2.0: Success in small steps","volume":"118","author":"Broughton","year":"2016","journal-title":"Circ. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/01.CIR.101.21.2490","article-title":"Clinical Profile and Outcome of Idiopathic Restrictive Cardiomyopathy","volume":"101","author":"Ammash","year":"2000","journal-title":"Circulation"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/0002-8703(92)90814-C","article-title":"Clinical profile and outcome of restrictive cardiomyopathy in children","volume":"123","author":"Lewis","year":"1992","journal-title":"Am. Heart J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ehf2.12142","article-title":"Cardiac and peripheral autonomic control in restrictive cardiomyopathy","volume":"4","author":"Sayegh","year":"2017","journal-title":"ESC Heart Fail."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.jacc.2005.03.050","article-title":"The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy","volume":"45","author":"Leya","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCIMAGING.114.002103","article-title":"Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy","volume":"7","author":"Amaki","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ihj.2015.05.012","article-title":"An unusual ECG pattern in restrictive cardiomyopathy","volume":"67","author":"Selvaganesh","year":"2015","journal-title":"Indian Heart J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","article-title":"Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document in collaboration with the \u201cWorking Group on myocardial and pericardial diseases\u201d of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography","volume":"18","author":"Habib","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: Cardiomyopathies that look alike","volume":"55","author":"Seward","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","article-title":"Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy","volume":"10","author":"Patel","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","article-title":"The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure","volume":"54","author":"Karamitsos","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive Cardiomyopathy","volume":"336","author":"Kushwaha","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1111\/j.1540-8159.2009.02383.x","article-title":"Restrictive Cardiomyopathy","volume":"32","author":"Zangwill","year":"2009","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.hfc.2010.05.005","article-title":"Restrictive Cardiomyopathy in Childhood","volume":"6","author":"Denfield","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ahj.2012.03.020","article-title":"Prevalence of Takotsubo cardiomyopathy in the United States","volume":"164","author":"Deshmukh","year":"2012","journal-title":"Am. Heart J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijcard.2016.02.012","article-title":"Takotsubo cardiomyopathy systematic review: Pathophysiologic process, clinical presentation and diagnostic approach to Takotsubo cardiomyopathy","volume":"209","author":"Ono","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Bauersachs","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e001056","DOI":"10.1161\/JAHA.114.001056","article-title":"Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: A nationwide population-based study","volume":"3","author":"Kolte","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2016.12.011","article-title":"Heart Failure in Late Pregnancy and Postpartum: Incidence and Long-Term Mortality in Sweden from 1997 to 2010","volume":"23","author":"Barasa","year":"2017","journal-title":"J. Card. Fail."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ejhf.882","article-title":"Peripartum cardiomyopathy in Denmark: A retrospective, population-based study of incidence, management and outcome","volume":"19","author":"Johansen","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy","volume":"485","author":"Patten","year":"2012","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Kaminski","year":"2007","journal-title":"Cell"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1172\/JCI64365","article-title":"MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy","volume":"123","author":"Halkein","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/eurheartj\/ehi481","article-title":"Peripartum cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospectively studied patients","volume":"27","author":"Sliwa","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","article-title":"Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation","volume":"111","author":"Elkayam","year":"2005","journal-title":"Circulation"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198505303122206","article-title":"Peripartum cardiomyopathy","volume":"312","author":"Homans","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0002-9149(92)90369-A","article-title":"Postpartum cardiomyopathy associated with maternal cocaine abuse","volume":"70","author":"Mendelson","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9378(93)90479-3","article-title":"Peripartum heart failure associated with prolonged tocolytic therapy","volume":"168","author":"Lampert","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1447-0756.2010.01378.x","article-title":"Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy","volume":"37","author":"Mandal","year":"2011","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2017.02.084","article-title":"Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations","volume":"235","author":"Akintoye","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jgyn.2010.01.008","article-title":"Evolution and thromboembolic complications of the idiopathic peripartal cardiomyopathy at Dakar University Hospital: Forward-looking study about 33 cases","volume":"39","author":"Kane","year":"2010","journal-title":"J. Gynecol. Obstet. Biol. Reprod."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/clc.23171","article-title":"IPAC Investigators Electrocardiographic findings in peripartum cardiomyopathy","volume":"42","author":"Honigberg","year":"2019","journal-title":"Clin. Cardiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejheart.2008.07.005","article-title":"Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy","volume":"10","author":"Forster","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1136\/heartjnl-2011-300349","article-title":"Diagnosis and management of peripartum cardiomyopathy","volume":"97","author":"Blauwet","year":"2011","journal-title":"Heart"},{"key":"ref_143","first-page":"234","article-title":"Echocardiographic profile of peripartum cardiomyopathy in a tertiary care hospital in sokoto, Nigeria","volume":"58","author":"Simeon","year":"2006","journal-title":"Indian Heart J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1253\/circj.CJ-16-1193","article-title":"Imbalanced Angiogenesis in Peripartum Cardiomyopathy- Diagnostic Value of Placenta Growth Factor","volume":"81","author":"Mebazaa","year":"2017","journal-title":"Circ. J."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study","volume":"121","author":"Sliwa","year":"2010","journal-title":"Circulation"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0735-1097(99)00161-8","article-title":"Intravenous immune globulin in the therapy of peripartum cardiomyopathy","volume":"34","author":"Bozkurt","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/ejcts\/ezu178","article-title":"Accelerated heart function recovery after therapeutic plasma exchange in patient treated with biventricular mechanical circulatory support for severe peripartum cardiomyopathy","volume":"46","author":"Lango","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jacc.2011.03.047","article-title":"Clinical characteristics of peripartum cardiomyopathy in the United States: Diagnosis, prognosis, and management","volume":"58","author":"Elkayam","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.jacc.2014.04.014","article-title":"Peripartum cardiomyopathy: Predictors of recovery and current state of implantable cardioverter-defibrillator use","volume":"63","author":"Pillarisetti","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy)","volume":"66","author":"McNamara","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/cphy.c140059","article-title":"Anthracycline-Induced Cardiomyopathy in Adults","volume":"5","author":"Tan","year":"2015","journal-title":"Compr. Physiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11764-014-0408-9","article-title":"Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin","volume":"9","author":"Qin","year":"2015","journal-title":"J. Cancer Surviv."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s12325-009-0048-z","article-title":"Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer","volume":"26","year":"2009","journal-title":"Adv. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","article-title":"Type II chemotherapy-related cardiac dysfunction: Time to recognize a new entity","volume":"23","author":"Ewer","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: A retrospective cohort study","volume":"104","author":"Bowles","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1200\/JCO.2016.67.4846","article-title":"Obesity as a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis","volume":"34","author":"Guenancia","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/1097-0142(19870915)60:6<1213::AID-CNCR2820600609>3.0.CO;2-V","article-title":"Acute arrhythmogenicity of doxorubicin administration","volume":"60","author":"Steinberg","year":"1987","journal-title":"Cancer"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/europace\/eum033","article-title":"Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator","volume":"9","author":"Rudzinski","year":"2007","journal-title":"Europace"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.eupc.2004.12.012","article-title":"Doxorubicin-induced second degree and complete atrioventricular block","volume":"7","author":"Kilickap","year":"2005","journal-title":"Europace"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjcard.2015.04.064","article-title":"Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy","volume":"116","author":"Wang","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1200\/JCO.2009.26.0463","article-title":"Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial","volume":"28","author":"Procter","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2011.40.0010","article-title":"Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer","volume":"30","author":"Romond","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1083-8791(00)70043-7","article-title":"Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer","volume":"6","author":"Nieto","year":"2000","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","article-title":"Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: Prognostic factors","volume":"25","author":"Brockstein","year":"2000","journal-title":"Bone Marrow Transpl."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/030089168407000305","article-title":"Ischemic cardiopathy from cis-diamminedichloroplatinum (CDDP)","volume":"70","author":"Tomirotti","year":"1984","journal-title":"Tumori"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/cncr.2820690525","article-title":"A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group study","volume":"69","author":"Mortimer","year":"1992","journal-title":"Cancer"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11886-019-1224-7","article-title":"Lamin A\/C Cardiomyopathy: Implications for Treatment","volume":"21","author":"Chen","year":"2019","journal-title":"Curr. Cardiol. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7722\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:32:01Z","timestamp":1760164321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":170,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147722"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147722","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]}}}